Your browser doesn't support javascript.
loading
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas.
Segura-Collar, Berta; Garranzo-Asensio, María; Herranz, Beatriz; Hernández-SanMiguel, Esther; Cejalvo, Teresa; Casas, Bárbara S; Matheu, Ander; Pérez-Núñez, Ángel; Sepúlveda-Sánchez, Juan Manuel; Hernández-Laín, Aurelio; Palma, Verónica; Gargini, Ricardo; Sánchez-Gómez, Pilar.
Afiliação
  • Segura-Collar B; Neurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Garranzo-Asensio M; Neurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Herranz B; Neurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Hernández-SanMiguel E; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.
  • Cejalvo T; Neurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Casas BS; Neurooncology Unit, Unidad Funcional de Investigación en Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Matheu A; Laboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile.
  • Pérez-Núñez Á; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.
  • Sepúlveda-Sánchez JM; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Hernández-Laín A; CIBERFES, Instituto de Salud Carlos III, Madrid, Spain.
  • Palma V; Dto. Neurocirugía, Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
  • Gargini R; Instituto de Investigaciones Biomédicas I+12, Hospital 12 de Octubre, Madrid, Spain.
  • Sánchez-Gómez P; Instituto de Investigaciones Biomédicas I+12, Hospital 12 de Octubre, Madrid, Spain.
Cancer Res ; 81(8): 2142-2156, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33593822
ABSTRACT
The extraordinary plasticity of glioma cells allows them to contribute to different cellular compartments in tumor vessels, reinforcing the vascular architecture. It was recently revealed that targeting glioma-derived pericytes, which represent a big percentage of the mural cell population in aggressive tumors, increases the permeability of the vessels and improves the efficiency of chemotherapy. However, the molecular determinants of this transdifferentiation process have not been elucidated. Here we show that mutations in EGFR stimulate the capacity of glioma cells to function as pericytes in a BMX- (bone marrow and X-linked) and SOX9-dependent manner. Subsequent activation of platelet-derived growth factor receptor beta in the vessel walls of EGFR-mutant gliomas stabilized the vasculature and facilitated the recruitment of immune cells. These changes in the tumor microenvironment conferred a growth advantage to the tumors but also rendered them sensitive to pericyte-targeting molecules such as ibrutinib or sunitinib. In the absence of EGFR mutations, high-grade gliomas were enriched in blood vessels, but showed a highly disrupted blood-brain barrier due to the decreased BMX/SOX9 activation and pericyte coverage, which led to poor oxygenation, necrosis, and hypoxia. Overall, these findings identify EGFR mutations as key regulators of the glioma-to-pericyte transdifferentiation, highlighting the intricate relationship between the tumor cells and their vascular and immune milieu. Our results lay the foundations for a vascular-dependent stratification of gliomas and suggest different therapeutic vulnerabilities determined by the genetic status of EGFR.

SIGNIFICANCE:

This study identifies the EGFR-related mechanisms that govern the capacity of glioma cells to transdifferentiate into pericytes, regulating the vascular and immune phenotypes of the tumors. GRAPHICAL ABSTRACT http//cancerres.aacrjournals.org/content/canres/81/8/2142/F1.large.jpg.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Pericitos / Transdiferenciação Celular / Microambiente Celular / Glioma / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Pericitos / Transdiferenciação Celular / Microambiente Celular / Glioma / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha